What Are the Safety Profiles and Contraindications for PT-141 in Diverse Patient Populations?
PT-141 is a centrally-acting peptide with a defined safety profile, contraindicated in cardiovascular disease due to transient pressor effects.
HRTioJuly 26, 2025